SOCRA CCRP Monitor 3

Question 1

What is risk-based monitoring (RBM) and why was it introduced in ICH-GCP E6(R2)?

Accepted Answer

An approach that focuses monitoring resources on critical data points and processes most likely to affect subject safety and data integrity

Answer

A method that eliminates all on-site monitoring

Answer

A cost-cutting measure that reduces monitor training requirements

Answer

A monitoring approach used only for Phase I trials

Question 2

What is the purpose of a close-out visit at the end of a clinical trial?

Accepted Answer

To ensure all trial activities are completed, documentation is finalized, and site obligations for record retention are communicated

Answer

To recruit additional subjects

Answer

To conduct the final data analysis

Answer

To file the marketing application

Question 3

What should a monitor verify regarding informed consent during routine monitoring visits?

Accepted Answer

That consents are properly signed and dated, were obtained before any study procedures, and are the current IRB-approved version

Answer

Only that consent forms exist in the file

Answer

That subjects received monetary compensation for signing

Answer

Only that the principal investigator signed the form

Question 4

What is centralized monitoring and how does it complement on-site monitoring?

Accepted Answer

It involves remote evaluation of accumulating data to identify patterns, trends, and anomalies across clinical trial sites

Answer

It replaces on-site monitoring entirely

Answer

It is monitoring performed only at the sponsor's headquarters

Answer

It is a type of quality assurance audit

Question 5

What information must be included in a monitoring visit report?

Accepted Answer

The date, site, monitor's name, findings, deviations noted, follow-up actions required, and a summary of key activities performed

Answer

Only a summary of the number of subjects enrolled

Answer

Only deviations and corrective actions

Answer

A complete copy of all source documents reviewed

Question 6

What is the monitor's role in managing Corrective and Preventive Actions (CAPAs) at a trial site?

Accepted Answer

The monitor identifies issues, recommends corrective actions, verifies implementation, and follows up to prevent recurrence

Answer

Monitors have no role in CAPAs

Answer

Monitors only document CAPAs without follow-up

Answer

CAPAs are exclusively handled by the quality assurance department